Business Context and Reporting Period
This Form 8-K is filed by Avista Healthcare Public Acquisition Corp. (AHPAC), a Cayman Islands exempted company and emerging growth company, dated February 14, 2018. The filing reports the termination of a material definitive agreement regarding a proposed business combination with Envigo International Holdings, Inc. (Envigo).
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. As a Special Purpose Acquisition Company (SPAC) in the process of terminating a merger, this report focuses on corporate actions rather than operational financial performance.
Material Changes
- Termination of Transaction Agreement: On February 14, 2018, AHPAC and Envigo entered into a Mutual Termination Agreement, effectively ending the Transaction Agreement originally signed on August 21, 2017, and subsequently amended four times.
- Termination of Sponsor Letter Agreement: The Amended and Restated Parent Sponsor Letter Agreement, which required the surrender of 4,715,576 Class B Shares and 4,100,000 Private Placement Warrants upon consummation of the merger, also terminated on February 14, 2018.
- Future Intent: AHPAC stated its intention to continue pursuing a business combination with another target.
Guidance, Outlook, and Risks
Outlook: Management intends to continue seeking a business combination, though no specific target or timeline is provided in this filing.
Risks and Contingencies: The filing includes a cautionary statement regarding forward-looking statements. Risks include international and local economic conditions, merger and acquisition risks, financing risks, geo-political risks, and acts of terror or war. The company disclaims any obligation to update these forward-looking statements.
Investor Verification Checklist
- Verify the status of AHPAC's trust account and the timeline for potential liquidation if a new business combination is not found.
- Confirm whether the termination of the Envigo deal triggers any specific redemption rights for public shareholders.
- Review subsequent filings for details on the new target company AHPAC intends to pursue.
- Check the most recent Form 10-K or 10-Q for the company's current cash position and working capital requirements.